761 results on '"Ganesan, Shridar"'
Search Results
2. Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC
3. Clinical efficacy of PARP inhibitors in breast cancer
4. Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer
5. SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity
6. The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA
7. Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
8. Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer
9. BRAF in Lung Cancers: Analysis of Patient Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent Alterations.
10. Subtype and cell type specific expression of lncRNAs provide insight into breast cancer
11. Understanding and overcoming resistance to PARP inhibitors in cancer therapy
12. SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis
13. Recurrence‐free survival dynamics following adjuvant chemotherapy for resected colorectal cancer: A systematic review of randomized controlled trials
14. Emerging strategies for treating metastasis
15. Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features
16. Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes
17. Reply to T. Ménard
18. Clustered 8-Oxo-Guanine Mutations and Oncogenic Gene Fusions in Microsatellite-Unstable Colorectal Cancer
19. Impact of Environmental Temperature on Clinical Outcomes and Tumor Microenvironment of Early-Stage Breast Cancer
20. Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community‐engaged development and pilot testing of a digital intervention
21. Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy
22. Collagen fiber orientation disorder from H&E images is prognostic for early stage breast cancer: clinical trial validation
23. Targetable alterations in invasive pleomorphic lobular carcinoma of the breast
24. Breaking satellite silence: human satellite II RNA expression in ovarian cancer
25. Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
26. Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response
27. Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers
28. PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response
29. Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing
30. Receptor-Defined Breast Cancer in Five East African Countries and Its Implications for Treatment: Systematic Review and Meta-Analysis
31. The Telomerase Reverse Transcriptase Regulates Chromatin State and DNA Damage Responses
32. Association of BRCA1 with the Inactive X Chromosome and XIST RNA
33. A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850
34. Abstract 3488: Truncated FGFR2 - a clinically actionable oncogene in multiple cancers
35. Supplementary Tables 1-2 from Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1-Mutated Mouse Mammary Tumors
36. Data from Mutational Landscape of the Essential Autophagy Gene BECN1 in Human Cancers
37. Supplementary Figures 1-10 from Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1-Mutated Mouse Mammary Tumors
38. Supplementary Data from Bcl-2 Modulation to Activate Apoptosis in Prostate Cancer
39. Supplementary Table 4 from Mutational Landscape of the Essential Autophagy Gene BECN1 in Human Cancers
40. Supplementary Table 1 from Mutational Landscape of the Essential Autophagy Gene BECN1 in Human Cancers
41. Data from Autophagy Opposes p53-Mediated Tumor Barrier to Facilitate Tumorigenesis in a Model of PALB2-Associated Hereditary Breast Cancer
42. Supplementary Table 3 from Mutational Landscape of the Essential Autophagy Gene BECN1 in Human Cancers
43. Supplementary Figures from Autophagy Opposes p53-Mediated Tumor Barrier to Facilitate Tumorigenesis in a Model of PALB2-Associated Hereditary Breast Cancer
44. Data from Bcl-2 Modulation to Activate Apoptosis in Prostate Cancer
45. Supplementary Table 2 from Mutational Landscape of the Essential Autophagy Gene BECN1 in Human Cancers
46. Supplementary Figure Legends 1-10 from Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1-Mutated Mouse Mammary Tumors
47. Supplementary Table 5 from Mutational Landscape of the Essential Autophagy Gene BECN1 in Human Cancers
48. Supporting Information from Autophagy Opposes p53-Mediated Tumor Barrier to Facilitate Tumorigenesis in a Model of PALB2-Associated Hereditary Breast Cancer
49. Next-Generation Sequencing Based Testing for Breast Cancer
50. Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.